v3.22.1
Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Statements of Operations    
Grant revenue $ 125,008 $ 242,061
Cost of grant revenue 125,008 242,061
Gross profit 0 0
Operating expenses:    
Research and development 828,547 260,880
General and administrative 852,949 600,686
Sales and marketing 219,429 62,578
Total operating expenses 1,900,925 924,144
Loss from operations (1,900,925) (924,144)
Interest expense, net (3,716) (6)
Net loss $ (1,904,641) $ (924,150)
Net loss per share - basic $ (0.31) $ (0.17)
Net loss per share - diluted $ (0.31) $ (0.17)
Weighted average number of shares outstanding - basic 6,155,352 5,344,025
Weighted average number of shares outstanding - diluted 6,155,352 5,344,025

Source